• Research/Demonstration Projects: Netherlands has an ongoing PrEP demonstration project, AMPrEP, for MSMs and transgender people.
  • Drug Registration: The European Medicines Agency approved Truvada for PrEP in 2016. The EMA is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union, but each member state will separately determine how, if at all, it might introduce PrEP.
  • Policy/Regulatory: There is no national policy or guidance at present.
  • Advocacy: The advocacy group PrEPnu is advocating for PrEP in the Netherlands and have a petition. If you’re a Netherlands advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

Last updated on September 1, 2017.

News Spotlight